What does CUSIP 86889P117 represent in this 13F holders report?

CUSIP 86889P117 is the security identifier for SRZNW - Surrozen, Inc./DE - *W EXP 08/01/203 used to aggregate holder disclosures.

How many institutions held SRZNW - Surrozen, Inc./DE - *W EXP 08/01/203 in Q1 2024?

14 institutional investors reported SRZNW - Surrozen, Inc./DE - *W EXP 08/01/203 for Q1 2024. Use the holders table for investor-level position and value details.

203 (SRZNW)

CUSIP: 86889P117

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class: Equity / *W EXP 08/01/203
Total 13F shares: 3,285,698
Total 13F value: $1,146,729
Share change: -53,061
SEC-reported price per share: $0.03
Number of holders: 14
Value change: -$1,024
Number of buys: 1
Number of sells: 3

Security key

86889P117

Report period

Q1 2024

Institutions

Top holders

SRZNW full security history Ownership snapshot Full 13F holder table Surrozen, Inc./DE SEC filings Surrozen, Inc./DE company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SRZNW - Surrozen, Inc./DE - *W EXP 08/01/203 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Column Group LLC

Disclosed value leader

Column Group LLC

Comparable rows

0/15

Latest evidence

31 Dec 2023

13F 3/4/5 Highest disclosed value: $5,899,919 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Column Group LLC has the largest disclosed position value at $5.9M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Column Group LLC's linked filing trail.

Disclosed position value Top 5

Column Group LLC $5.9M

Euclidean Capital LLC $827.7K

Benny Soffer $716.3K

Kevin Harold Livingston $716.3K

Life Sciences Consonance $716.3K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Column Group LLC	13F Company 13F	— denominator unverified	$5,899,919 627,651 shares	—	31 Dec 2023
Euclidean Capital LLC	13F Company 13F	— mixed-class rows	$827,656 258,529 shares mixed-class rows	—	31 Dec 2023
Benny Soffer	3/4/5 FORMER DIRECTOR 3/4/5	— mixed-class rows	$716,300 2,029,667 shares mixed-class rows	—	11 Aug 2021
Kevin Harold Livingston	3/4/5 Former Chief Financial Officer 3/4/5	— mixed-class rows	$716,300 2,029,667 shares mixed-class rows	—	11 Aug 2021
Life Sciences Consonance	3/4/5 Former 10% Holder 3/4/5	— mixed-class rows	$716,300 2,029,667 shares mixed-class rows	—	11 Aug 2021
EcoR1 Capital, LLC	13F Company 13F	— denominator unverified	$626,651 66,665 shares	—	31 Dec 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,285,698

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q1 2024 value	Value change	Value Chg %